Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 655 plus doxorubicin in soft tissue sarcoma
NCT00626704Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2007
- Primary completion
- Aug 2009
01
Overview
Phase 2, randomised, double-blind trial of conatumumab in soft tissue sarcoma (STS), sponsored by Amgen. Started Nov 2007; status: completed.
02
Drugs
conatumumab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00626704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626704.